2026 NPPES data Radiation Oncology Physician NPI 1326081563 M.D.
Verify on CMS →

EDWIN RODRIGUEZ APONTE, M.D.

Radiation Oncology Physician in ARECIBO, Puerto Rico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
177
Medicare Part D claims · 101 beneficiaries · Radiation Oncology Physician avg: 186
Generic prescribing
69%
generic claims · 31% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$72.67
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: EDWIN RODRIGUEZ APONTE, M.D. is a Radiation Oncology Physician ([object Object]) practicing in ARECIBO, Puerto Rico with a Medicare Part D prescribing footprint of 177 claims across 101 beneficiaries — 31% brand-name prescribing . Industry payments of $72.67 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: EDWIN RODRIGUEZ APONTE, M.D. filed 177 Medicare Part D claims in 2023 across ARECIBO, Puerto Rico. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

EDWIN RODRIGUEZ APONTE, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

EDWIN RODRIGUEZ APONTE, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 06/14/2006

NPI 1326081563

Primary specialty

Radiation Oncology Physician

Mid-sized

6,018 US NPIs in this specialty

Medicare Part D claims

177 5% vs specialty avg

2023 prescription claims

Specialty avg: 186

Specialty distribution in Puerto Rico

How Radiation Oncology Physician compares to other specialties among Puerto Rico providers

Puerto Rico providers

Radiation Oncology Physician share within Puerto Rico

1. Radiation Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Radiation Oncology Physician share within Puerto Rico

Specialty board-certification context

Estimated specialty board-certified rate — Radiation Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Radiation Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Radiation Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Radiation Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

EDWIN RODRIGUEZ APONTE, M.D. is a Radiation Oncology Physician provider practicing in ARECIBO, Puerto Rico, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1326081563. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

EDWIN RODRIGUEZ APONTE, M.D. appears in the CMS NPPES registry as a Radiation Oncology Physician provider holding M.D. credentials at AVE SAN LUIS 750, ARECIBO, PR, 00612, with a listed phone of (787) 650-6070. NPI 1326081563 was issued on 06/14/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RODRIGUEZ APONTE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 177 prescription claims written by this provider, covering 101 Medicare beneficiaries and totaling roughly $5K in drug spend, split 31% brand-name and 69% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Radiation Oncology Physician is a mid-sized specialty nationwide, with 6,018 enrolled providers across 52 states and an average of 186 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

AVE SAN LUIS 750
ARECIBO, PR 00612

Provider Details

NPI 1326081563
Specialty Radiation Oncology Physician
Credentials M.D.
Gender Male
NPI Issued 06/14/2006

Hospital and facility affiliations

Facilities where EDWIN RODRIGUEZ APONTE, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

METROHEALTH RADIATION ONCOLOGY GROUP, INC.
AGUADILLA, PR

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for EDWIN RODRIGUEZ APONTE, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$73

Largest payer

Teleflex LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

EDWIN RODRIGUEZ APONTE, M.D. — brand share 31.0%
Specialty average (est.)

31% brand-name claims vs 69% generic, on 177 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

177
Total Claims
$5K
Total Drug Cost
101
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
181
Total Day Supply
2,915
Brand vs Generic
31% brand / 69% generic
Brand Drug Cost
$2K
Generic Drug Cost
$3K

Patient Demographics

Average Patient Age
71.6 years
Avg HCC Risk Score
2.07
Gender Split
70% female / 30% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Betamethasone Dipropionate
68
Silver Sulfadiazine
30
Clotrimazole-Betamethasone
Clotrimazole/Betamethasone Dip
22
Lidocaine Hcl Viscous
Lidocaine Hcl
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Radiation Oncology Physician Overview

How EDWIN RODRIGUEZ APONTE, M.D. fits within the Radiation Oncology Physician landscape nationally.

6,018
Radiation Oncology Physician Providers in US
52
States with Radiation Oncology Physician
186
Avg Claims per Provider

EDWIN RODRIGUEZ APONTE, M.D.'s 177 claims are below the specialty average of 186.

Nearby Radiation Oncology Physician Providers in Puerto Rico

Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as RODRIGUEZ APONTE.

Compare Radiation Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is EDWIN RODRIGUEZ APONTE, M.D.'s specialty?
EDWIN RODRIGUEZ APONTE, M.D. specializes in Radiation Oncology Physician and practices in ARECIBO, Puerto Rico. Credentials: M.D..
How much does EDWIN RODRIGUEZ APONTE, M.D. prescribe under Medicare Part D?
In 2023, EDWIN RODRIGUEZ APONTE, M.D. wrote 177 Medicare Part D claims totaling $5K in drug costs for 101 beneficiaries.
Where is EDWIN RODRIGUEZ APONTE, M.D. located?
EDWIN RODRIGUEZ APONTE, M.D. is located at AVE SAN LUIS 750, ARECIBO, PR, 00612. Phone: (787) 650-6070.
What is EDWIN RODRIGUEZ APONTE, M.D.'s NPI number?
EDWIN RODRIGUEZ APONTE, M.D.'s National Provider Identifier (NPI) is 1326081563, issued on 06/14/2006.
Does EDWIN RODRIGUEZ APONTE, M.D. prescribe more brand-name or generic drugs?
EDWIN RODRIGUEZ APONTE, M.D.'s prescribing is 31% brand-name and 69% generic drugs by claim count, with $2K in brand drug costs.
How many Radiation Oncology Physician providers are there in the US?
There are 6,018 Radiation Oncology Physician providers across 52 states in the US. The average Radiation Oncology Physician provider writes 186 Medicare Part D claims per year.
What drugs does EDWIN RODRIGUEZ APONTE, M.D. prescribe most often?
Based on 2023 Medicare Part D data, EDWIN RODRIGUEZ APONTE, M.D.'s most frequently prescribed drugs include Betamethasone Dipropionate, Silver Sulfadiazine, Clotrimazole-Betamethasone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does EDWIN RODRIGUEZ APONTE, M.D. accept Medicare?
EDWIN RODRIGUEZ APONTE, M.D. appears in CMS Medicare data with 177 Part D claims and 101 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify EDWIN RODRIGUEZ APONTE, M.D.'s credentials?
EDWIN RODRIGUEZ APONTE, M.D.'s NPI is 1326081563 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology